Power Law company profile

Xvivo perfusion

Biotech & Life Sciences · Göteborgs Stad, Sweden · Founded 1998 · IPO 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.03B

Market cap · Apr/2026

Revenue

$98M

Latest reported FY

Patent intelligence

$15M patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$15M

1.5% of market cap · 60.3× smaller than top peer Globus Medical ($930M)

8 active patent families

Where Xvivo perfusion innovates Biomedical engineeringBlood vesselDextranEx vivoBlood serum

Above peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

Xvivo perfusion on the five Patsnap quality dimensions

Xvivo perfusion in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Xvivo perfusion concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Xvivo perfusion and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Xvivo perfusion on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo